Takeda spinning out eight candidates to newco Scohia

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it will spin out eight diabetes, renal and cardiovascular disease candidates into newco

Read the full 192 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE